Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 10/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 10/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6862330 | 1.00 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| Hydrochloric Acid SCHEMBL30819446 | 0.99 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| Trimethylammonium SCHEMBL27504350 | 0.85 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| Trimethylammonium SCHEMBL27503278 | 0.85 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| SCHEMBL27489241 | 0.82 | SLC6A2 (0.58) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| SCHEMBL7964628 | 0.82 | SLC6A2 (0.58) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| SCHEMBL8098946 | 0.80 | SLC6A2 (0.56) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| SCHEMBL31682199 | 0.79 | SLC6A2 (0.53) | SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4 | |
| SCHEMBL2637137 | 0.77 | KDM4E (0.56) | SLC6A2SLC6A4SLC6A3KDM4EOPRM1 | |
| SCHEMBL8407276 | 0.77 | KDM4E (0.56) | SLC6A2SLC6A4SLC6A3KDM4EOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6576648-B2 | 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-( 1H-indol-3-ylmethyl)-2-oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production | NOVO NORDISK A/S (DK) | 2003-06-10 | — | — | US | disclosed |
| EP-1230236-A1 | COMPOUND WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 2002-08-14 | — | — | EP | disclosed |
| US-20010041720-A1 | Compound with growth hormone releasing properties | NOVO NORDISK A/S (DK) | 2001-11-15 | — | — | US | disclosed |
| WO-2001034593-A1 | COMPOUND WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 2001-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041720-A1 | Compound with growth hormone releasing properties | GHRHR, GHSR, PRLHR | SLC6A2 1068/4885SLC6A4 742/4885SLC6A3 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.